Database and news
Peptides
Research peptides, clinic marketing, access and quality risk coverage
Peptide regulatory status tracker
Where each peptide stands with FDA: its 503A bulks-list status, any FDA-approved product, advisory committee votes and anti-doping status, with the source for every change.
- FDA-approved Bones & muscles
Abaloparatide
Abaloparatide is an FDA-approved PTHrP analog injection for osteoporosis. Learn how it builds bone, what the ACTIVE trial found, and its two-year limit.
- FDA-approved Skin & aging
Afamelanotide
Afamelanotide is a synthetic form of a skin hormone, FDA-approved in 2019 as the Scenesse implant for adults with EPP. See how it works and what trials show.
- FDA-approved Hormones & metabolism
Albiglutide
Albiglutide is a once-weekly GLP-1 drug approved in 2014 as Tanzeum for type 2 diabetes. Learn how it works, what trials found, and why it was withdrawn.
- FDA-approved Heart & blood
Angiotensin II
Angiotensin II is a natural hormone that raises blood pressure. A synthetic form, Giapreza, is FDA-approved for shock. See how it works and what trials show.
- FDA-approved Skin & aging
Bacitracin
Bacitracin is an FDA-approved peptide antibiotic used on the skin for minor wounds. Learn how it works, how it is used, and why it can cause allergies.
- FDA-approved Heart & blood
Bivalirudin
Bivalirudin (Angiomax) is an FDA-approved peptide anticoagulant used during heart procedures. Learn how it works, when it is used, and what trials found.
- FDA-approved Brain & sleep
Bremelanotide
Bremelanotide is an FDA-approved melanocortin agonist sold as Vyleesi for HSDD in premenopausal women. See how it works, side effects, and the PT-141 caveat.
- FDA-approved Bones & muscles
Calcitonin-salmon
Miacalcin (injection), nasal spray sold as a generic
Calcitonin-salmon is an FDA-approved hormone copy used for osteoporosis, Paget's disease, and high blood calcium. Learn how it works and where it fits.
- FDA-approved Sexual & reproductive
Cetrorelix
Cetrorelix is an FDA-approved GnRH antagonist sold as Cetrotide. Learn how it prevents early ovulation during IVF stimulation and where it fits.
- FDA-approved Hormones & metabolism
Corticotropin
ACTH
Corticotropin (ACTH) stimulates the adrenal glands and acts on immune cells. Learn what it is, how it works, and its FDA-approved status since 1952.
- FDA-approved Hormones & metabolism
Cosyntropin
Cosyntropin is a synthetic ACTH fragment used to test adrenal function. Learn how the cortisol response is read and what FDA-approved means here.
- FDA-approved Immune & defense
Cyclosporine
Cyclosporine is a cyclic peptide that suppresses T cells. Learn how it works, its FDA-approved forms, and why systemic versions carry boxed warnings.
- FDA-approved Skin & aging
Dalbavancin / Oritavancin / Telavancin
Dalbavancin, oritavancin, and telavancin are FDA-approved lipoglycopeptide antibiotics for Gram-positive infections. See how they work and differ.
- FDA-approved Skin & aging
Daptomycin
Daptomycin is an FDA-approved intravenous antibiotic for serious skin infections and Staph aureus bloodstream infections. Learn how it works and its uses.
- FDA-approved Digestive & weight
Dasiglucagon
Dasiglucagon is an FDA-approved, ready-to-use glucagon analog for severe low blood sugar. Learn how it works, what it is used for, and its side effects.
- FDA-approved Sexual & reproductive
Degarelix
Degarelix is an FDA-approved GnRH antagonist for advanced prostate cancer that lowers testosterone quickly. Learn how it works and its side effects.
- FDA-approved Heart & blood
Desirudin
Desirudin is a recombinant hirudin once used to prevent clots after hip surgery. Learn how it blocks thrombin and why it is no longer sold in the U.S.
- FDA-approved Heart & blood
Desmopressin
Desmopressin is a synthetic vasopressin analog approved by the FDA since 1978. Learn how it concentrates urine, its approved uses, and its main safety risk.
- FDA-approved Skin & aging
Difelikefalin
Difelikefalin (Korsuva) is an FDA-approved peptide for itch in adults on hemodialysis. Learn how it works, what the trials showed, and its side effects.
- FDA-approved Hormones & metabolism
Dulaglutide
Dulaglutide is an FDA-approved once-weekly GLP-1 receptor agonist for type 2 diabetes. Learn how it works, what trials showed, and its cardiovascular role.
- FDA-approved Skin & aging
Ecallantide
Ecallantide is an FDA-approved plasma kallikrein inhibitor for acute hereditary angioedema attacks. Learn how it works, who gives it, and its boxed warning.
- FDA-approved Heart & blood
Echinocandins
Echinocandins are FDA-approved antifungal lipopeptides that block the fungal cell wall. Learn how caspofungin, micafungin, and anidulafungin work and are used.
- FDA-approved Immune & defense
Enfuvirtide
Enfuvirtide (Fuzeon) blocks HIV from entering CD4 cells. See how this fusion inhibitor works, who used it, its 2003 FDA approval, and its 2025 discontinuation.
- FDA-approved Heart & blood
Eptifibatide
Eptifibatide (Integrilin) is an intravenous peptide that blocks platelet clumping during heart attacks and stenting. Learn how it works and its bleeding risk.
- FDA-approved Bones & muscles
Etelcalcetide
Etelcalcetide (Parsabiv) is an intravenous peptide that lowers parathyroid hormone in people on dialysis. Learn how it works and what it is approved for.
- FDA-approved Hormones & metabolism
Exenatide
Exenatide is a GLP-1 agonist FDA-approved in 2005 for type 2 diabetes. Learn how it works, its history, and why the U.S. brands were discontinued.
- FDA-approved Digestive & weight
Ga-68 dotatate
Gallium Ga-68 dotatate (NETSPOT) is an FDA-approved PET tracer that locates neuroendocrine tumors. Learn how it works, what it is used for, and side effects.
- FDA-approved Sexual & reproductive
Ganirelix
Ganirelix is an FDA-approved GnRH antagonist peptide that prevents early ovulation during IVF. Learn how it works, what it is used for, and its side effects.
- FDA-approved Digestive & weight
Glucagon
Glucagon is a pancreatic hormone that raises blood sugar fast. Learn its role in severe hypoglycemia, how nasal and injectable forms compare, and its status.
- FDA-approved Sexual & reproductive
Goserelin
Goserelin (Zoladex) is an FDA-approved GnRH agonist implant. Learn how it lowers sex hormones and what it is used for in cancer and endometriosis.
- FDA-approved Sexual & reproductive
Histrelin
Histrelin is an FDA-approved GnRH agonist implant for central precocious puberty. Learn how it works, its side effects, and the evidence behind it.
- FDA-approved Sexual & reproductive
Human chorionic gonadotropin
hCG is an FDA-approved hormone that mimics luteinizing hormone. Learn its approved uses, how it works, its risks, and why it is not approved for weight loss.
- FDA-approved Skin & aging
Icatibant
Icatibant is an FDA-approved peptide that blocks the bradykinin B2 receptor in hereditary angioedema attacks. Learn how it works and its side effects.
- FDA-approved Hormones & metabolism
Insulin analogs
Insulin analogs are engineered insulins that act faster or last longer. Learn how they work, their uses, their FDA status, and side effects.
- FDA-approved Digestive & weight
Lanreotide
Lanreotide is a long-acting somatostatin analog FDA-approved since 2007 for acromegaly and certain neuroendocrine tumors. Learn how it works and its risks.
- FDA-approved Sexual & reproductive
Leuprolide
Leuprolide is a GnRH agonist FDA-approved since 1985. It suppresses testosterone and estrogen for prostate cancer, endometriosis, and precocious puberty.
- FDA-approved Digestive & weight
Linaclotide
Linaclotide (Linzess) is an FDA-approved peptide that acts inside the gut to ease IBS-C and chronic constipation. Learn how it works and its risks.
- FDA-approved Digestive & weight
Liraglutide
Liraglutide, sold as Victoza and Saxenda, is a once-daily GLP-1 agonist for type 2 diabetes and weight management. Learn how it works and its evidence.
- FDA-approved Hormones & metabolism
Lixisenatide
Lixisenatide is a once-daily GLP-1 receptor agonist FDA-approved in 2016 for type 2 diabetes. See how it works, its status, and side effects.
- FDA-approved Digestive & weight
Lutetium Lu-177 dotatate
Lutetium Lu-177 dotatate (Lutathera) is an FDA-approved radiation therapy for neuroendocrine tumors. See how it works, uses, and side effects.
- FDA-approved Sexual & reproductive
Lutetium Lu-177 vipivotide tetraxetan
Pluvicto
Lu-177 vipivotide tetraxetan (Pluvicto) is an FDA-approved radiation therapy for PSMA-positive prostate cancer. See how it works and side effects.
- FDA-approved Hormones & metabolism
Mecasermin
Mecasermin is recombinant IGF-1, FDA-approved since 2005 for children with severe primary IGF-1 deficiency. Learn how it works and who it is for.
- FDA-approved Heart & blood
Motixafortide
Aphexda
Motixafortide is an FDA-approved CXCR4-blocking peptide that moves stem cells into the blood for collection in multiple myeloma. Learn how it works.
- FDA-approved Sexual & reproductive
Nafarelin
Synarel
Nafarelin is an FDA-approved GnRH agonist nasal spray for endometriosis and central precocious puberty. See how it works and what trials show.
- FDA-approved Heart & blood
Nesiritide
Nesiritide is a lab-made copy of the heart hormone BNP, approved for acute heart failure. See how it works, what trials found, and its side effects.
- FDA-approved Digestive & weight
Octreotide
Octreotide is an FDA-approved somatostatin analog used for acromegaly and hormone-secreting tumors. Learn how it works, its forms, and side effects.
- FDA-approved Sexual & reproductive
Oxytocin
Oxytocin is a nine-amino-acid pituitary hormone. Learn how it makes the uterus contract, why it is FDA-approved for labor, and its side effects.
- FDA-approved Bones & muscles
Palopegteriparatide
Yorvipath
Palopegteriparatide (Yorvipath) is an FDA-approved, long-acting parathyroid hormone for adults with hypoparathyroidism. Learn how it works and what trials show.
- FDA-approved Bones & muscles
Parathyroid hormone
Natpara
Parathyroid hormone (Natpara) is an FDA-approved replacement for hypoparathyroidism. Learn how it works, trial results, and the boxed warning.
- FDA-approved Hormones & metabolism
Pasireotide
Signifor
Pasireotide (Signifor) is an FDA-approved somatostatin analog for Cushing's disease and acromegaly. Learn how it works and why it raises blood sugar.
- FDA-approved Heart & blood
Pegcetacoplan
Pegcetacoplan is an FDA-approved peptide that blocks complement C3. Learn how Empaveli and Syfovre work, what each is approved for, and key safety points.
- FDA-approved Hormones & metabolism
Pegvisomant
Pegvisomant (Somavert) is an FDA-approved growth hormone receptor blocker for acromegaly. Learn how it lowers IGF-1, how it is given, and the research.
- FDA-approved Digestive & weight
Plecanatide
Plecanatide is an FDA-approved oral peptide for chronic constipation and IBS-C. Learn how it works, what trials showed, and its boxed dehydration warning.
- FDA-approved Immune & defense
Polymyxin B / Colistin
Polymyxin B and colistin are FDA-approved last-resort antibiotics for resistant Gram-negative infections. Learn how they work and why their use is limited.
- FDA-approved Hormones & metabolism
Pramlintide
Pramlintide is an FDA-approved amylin analog used with mealtime insulin. Learn how it lowers after-meal glucose and how it differs from GLP-1 drugs.
- FDA-approved Hormones & metabolism
Secretin
Secretin is the first hormone ever discovered and an FDA-approved diagnostic agent. Learn how it tests pancreatic function and what the evidence shows.
- FDA-approved Digestive & weight
Semaglutide
Semaglutide is a GLP-1 receptor agonist sold as Ozempic, Wegovy, and Rybelsus. Learn how it works, what it is approved for, and its side effects.
- FDA-approved Digestive & weight
Setmelanotide
Imcivree
Setmelanotide, sold as Imcivree, is an FDA-approved peptide for certain rare genetic obesity. Learn how it works, who it is for, and its side effects.
- FDA-approved Digestive & weight
Sincalide
Kinevac
Sincalide, sold as Kinevac, is an FDA-approved diagnostic peptide that triggers gallbladder contraction. Learn how it works, its uses, and side effects.
- FDA-approved Hormones & metabolism
Somapacitan
Sogroya
Somapacitan is a long-acting growth hormone, FDA-approved since 2020, given once weekly. Learn how it works, who it is for, and how it differs from daily doses.
- FDA-approved Hormones & metabolism
Somatropin (rhGH)
rhGH
Somatropin is lab-made human growth hormone, FDA-approved since the late 1980s. Learn its approved uses, how it works, and the safety considerations involved.
- FDA-approved Digestive & weight
Teduglutide
Gattex
Teduglutide is a GLP-2 analog, FDA-approved since 2012, for short bowel syndrome. Learn how it helps the gut absorb nutrients, who uses it, and key risks.
- FDA-approved Bones & muscles
Teriparatide
Teriparatide (Forteo) is an FDA-approved parathyroid hormone fragment that builds new bone in people at high fracture risk from osteoporosis.
- FDA-approved Digestive & weight
Terlipressin
Terlipressin (Terlivaz) is an FDA-approved vasopressin analog that improves kidney function in hepatorenal syndrome. Learn how it works and its boxed warning.
- FDA-approved Digestive & weight
Tesamorelin
Tesamorelin (Egrifta) is an FDA-approved growth hormone-releasing hormone analog that reduces excess abdominal fat in people with HIV-associated lipodystrophy.
- FDA-approved Digestive & weight
Tirzepatide
Tirzepatide is an FDA-approved once-weekly peptide that activates GIP and GLP-1 receptors. Learn its approved uses, how it works, and trial results.
- FDA-approved Sexual & reproductive
Triptorelin
Triptorelin is an FDA-approved GnRH agonist given as a depot injection. Learn its approved uses, how it lowers testosterone, and what trials show.
- FDA-approved Brain & sleep
Trofinetide
DAYBUE and DAYBUE STIX
Trofinetide (DAYBUE) is an FDA-approved drug for Rett syndrome. Learn how it works, what it is prescribed for, its side effects, and the evidence.
- FDA-approved Heart & blood
Vancomycin
Vancomycin is an FDA-approved antibiotic for serious Gram-positive infections, including MRSA and C. difficile. Learn how it works, its uses, and side effects.
- FDA-approved Heart & blood
Vasopressin
Vasopressin (Vasostrict) is an FDA-approved hormone used in intensive care to raise blood pressure. Learn how it works, its uses, and side effects.
- FDA-approved Bones & muscles
Vosoritide
Vosoritide (Voxzogo) is an FDA-approved peptide that increases growth in children with achondroplasia. Learn how it works, its side effects, and the evidence.
- FDA-approved Brain & sleep
Ziconotide
Ziconotide (Prialt) is an FDA-approved non-opioid peptide for severe chronic pain, given by spinal pump. Learn how it works and its boxed warning.
- FDA-approved Bones & muscles
Zilucoplan
Zilucoplan (Zilbrysq) is an FDA-approved peptide that blocks complement C5 in antibody-positive myasthenia gravis. Learn how it works and its risks.
| Peptide | Status | 503A bulks list | FDA-approved product | WADA |
|---|---|---|---|---|
| Abaloparatide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Afamelanotide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Albiglutide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Angiotensin II | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Bacitracin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Bivalirudin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Bremelanotide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Calcitonin-salmon Miacalcin (injection), nasal spray sold as a generic | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Cetrorelix | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Corticotropin ACTH | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Cosyntropin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Cyclosporine | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Dalbavancin / Oritavancin / Telavancin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Daptomycin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Dasiglucagon | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Degarelix | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Desirudin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Desmopressin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Difelikefalin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Dulaglutide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Ecallantide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Echinocandins | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Enfuvirtide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Eptifibatide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Etelcalcetide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Exenatide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Ga-68 dotatate | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Ganirelix | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Glucagon | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Goserelin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Histrelin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Human chorionic gonadotropin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Icatibant | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Insulin analogs | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Lanreotide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Leuprolide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Linaclotide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Liraglutide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Lixisenatide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Lutetium Lu-177 dotatate | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Lutetium Lu-177 vipivotide tetraxetan Pluvicto | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Mecasermin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Motixafortide Aphexda | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Nafarelin Synarel | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Nesiritide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Octreotide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Oxytocin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Palopegteriparatide Yorvipath | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Parathyroid hormone Natpara | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Pasireotide Signifor | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Pegcetacoplan | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Pegvisomant | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Plecanatide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Polymyxin B / Colistin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Pramlintide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Secretin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Semaglutide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Setmelanotide Imcivree | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Sincalide Kinevac | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Somapacitan Sogroya | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Somatropin (rhGH) rhGH | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Teduglutide Gattex | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Teriparatide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Terlipressin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Tesamorelin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Tirzepatide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Triptorelin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Trofinetide DAYBUE and DAYBUE STIX | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Vancomycin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Vasopressin | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Vosoritide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Ziconotide | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
| Zilucoplan | FDA-approved | Not nominated Since Sept. 28, 2026, as of Oct. 27, 2026 | Yes — see profile | Not listed |
Source: FDA 503A bulks-list categories, PCAC meeting materials and the WADA Prohibited List
Status labels Not FDA-approved Research use only FDA-approved Investigational Compounded (503A)
What each label means
- Not FDA-approved
- No FDA approval for any use in humans.
- Research use only
- Sold as a "research chemical" not for human use. Not FDA-approved; FDA considers such products unapproved new drugs when marketed for human use.
- FDA-approved
- FDA has approved this drug or biologic as safe and effective for its labeled use.
- Investigational
- Being studied in clinical trials; not approved by FDA for any use.
- Compounded (503A)
- Prepared by a state-licensed 503A pharmacy for an individual patient prescription. Compounded drugs are not FDA-approved.
About peptide status
Most peptides discussed here are not FDA-approved for any use, and products labeled “research use only” are not for human use. Removal from Category 2 does not authorize compounding. PCAC votes are non-binding recommendations; FDA and HHS make the final decisions.
This is not medical or legal advice, and we do not publish dosing, sourcing or reconstitution information. Talk with a licensed clinician before using any peptide.
If you think you are having a medical emergency, call 911.
Methodology
Data sources
What we include
- Peptides that are marketed to consumers through telehealth, compounding pharmacies or “research use only” sellers, or that FDA or its advisory committee has reviewed for the 503A bulks list.
- The 503A status is the one on FDA’s published lists on the “status as of” date; advisory committee votes are recorded as non-binding recommendations.
How we verify
- Every status change is dated and linked to the FDA page or meeting materials it comes from.
- Profiles are reviewed by a clinician or pharmacist on our medical review panel.
Known gaps
- 503B (outsourcing facility) status is recorded only when FDA has stated it.
- Advisory committee outcomes are sometimes reported before FDA posts minutes; those records say so.
- Human trial counts cover registered trials we reviewed, not every published study.
Update frequency: Checked at least weekly and whenever FDA updates its 503A lists or holds a PCAC meeting.
CSV columns (19)
-
profile_url - Peptide profile on this site.
-
name - Peptide name.
-
synonyms - Other names, separated by semicolons.
-
status_503a - 503A bulks-list status code.
-
status_503a_label - 503A bulks-list status in plain English.
-
status_503b - 503B (outsourcing facility) status, when known.
-
fda_approved - true when an FDA-approved drug product contains the peptide.
-
approved_product - The FDA-approved product, when there is one.
-
wada - World Anti-Doping Agency status (Prohibited, Not listed, Not assessed).
-
dea_schedule - DEA controlled-substance schedule, when assessed.
-
status_labels - Status Label codes shown on the page, separated by semicolons.
-
last_status_change - Date of the current 503A status (YYYY-MM-DD): the advisory committee vote, FDA listing or bulks-list effective date, by status.
-
status_source_url - FDA document for the current status.
-
status_as_of - Date we last verified the status.
-
human_trial_count - Registered human trials we reviewed on ClinicalTrials.gov.
-
trial_ids - ClinicalTrials.gov NCT numbers, separated by semicolons.
-
unii - FDA Unique Ingredient Identifier.
-
last_reviewed - Date of the last medical/editorial review (YYYY-MM-DD).
-
last_updated - When this record last changed (ISO 8601).
“Peptide regulatory status tracker.” Tele Launched (dataset). Updated Oct. 27, 2026. Accessed Nov. 7, 2026. https://telelaunched.com/peptides/